These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 9890272

  • 21. Protection against murine intestinal amoebiasis induced by oral immunization with the 29 kDa antigen of Entamoeba histolytica and cholera toxin.
    Carrero JC, Contreras-Rojas A, Sánchez-Hernández B, Petrosyan P, Bobes RJ, Ortiz-Ortiz L, Laclette JP.
    Exp Parasitol; 2010 Nov; 126(3):359-65. PubMed ID: 20303954
    [Abstract] [Full Text] [Related]

  • 22. Seroepidemiology of anti-Entamoeba histolytica antibody by enzyme-linked immunosorbent assay in the greater Tokyo area.
    Tanaka T, Kaneda Y.
    Tokai J Exp Clin Med; 1991 Dec; 16(5-6):253-8. PubMed ID: 1820666
    [Abstract] [Full Text] [Related]

  • 23. Seroprevalence of Entamoeba histolytica infection in female outpatients at a sexually transmitted disease sentinel clinic in Tokyo, Japan.
    Suzuki J, Kobayashi S, Iku I, Murata R, Yanagawa Y, Takeuchi T.
    Jpn J Infect Dis; 2008 May; 61(3):175-8. PubMed ID: 18503164
    [Abstract] [Full Text] [Related]

  • 24. Detection of anti-Entamoeba histolytica IgA salivary antibodies: evaluation of its diagnostic capability in a rural setting.
    Escandón Romero C, Gómez Hernández JL, Cabral Soto J, Hernández Ramos JM, Escobedo-de la Peña J, Olvera Alvarez J.
    Arch Med Res; 1997 May; 28 Spec No():306-8. PubMed ID: 9033112
    [No Abstract] [Full Text] [Related]

  • 25. The use of an ELISPOT assay to evaluate intestinal and systemic antibody responses to locally administered Entamoeba histolytica antigen in mice.
    Moreno-Fierros L, Domínguez-Robles MC, Enríquez-Rincón F.
    Arch Med Res; 1994 May; 25(2):183-7. PubMed ID: 7919810
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of an immunoblot methodology for the detection of relevant Entamoeba histolytica antigens by antibodies induced in human amebiasis.
    Argüello-García R, Sánchez-Guillén MC, Garduño G, Valadez-Salazar A, Martínez-García MC, Muñoz O, Ortega-Pierres MG.
    Arch Invest Med (Mex); 1990 May; 21 Suppl 1():3-9. PubMed ID: 2136499
    [Abstract] [Full Text] [Related]

  • 27. Dot-enzyme-linked immunosorbent assay (Dot-ELISA) of anti-Entamoeba histolytica antibodies in human serum and colostrum.
    López Revilla R, Navarro-García F, Valadez-Sánchez M, López Vidal Y, Calva Mercado J.
    Arch Invest Med (Mex); 1991 May; 22(3-4):249-53. PubMed ID: 1844108
    [Abstract] [Full Text] [Related]

  • 28. An Entamoeba histolytica antigen devoid of enzymatic activity, but endowed with immunogenic and protective properties.
    Portnoy L, Oliva A, Antonio-Ramírez J, Castellanos C, del Muro R, Ortíz-Ortíz L.
    Arch Invest Med (Mex); 1990 May; 21 Suppl 1():27-34. PubMed ID: 2136496
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. IgA reactivity in patients with intestinal or hepatic amebiasis.
    Rangel A, Mora N, Espinoza A, Cristancho M, Hernández M.
    Arch Med Res; 1992 May; 23(2):259-60. PubMed ID: 1340308
    [Abstract] [Full Text] [Related]

  • 31. [Fecal and serum anti-amebic antibodies in acute intestinal amebiasis].
    Ximénez C, Hernández J, Melendro EI, Ramíro M.
    Arch Invest Med (Mex); 1990 May; 21 Suppl 1():239-44. PubMed ID: 2136492
    [Abstract] [Full Text] [Related]

  • 32. Amoebiasis in foreign students.
    Giboda M, Ditrich O, Vokurková-Vrchotová N.
    Folia Parasitol (Praha); 1990 May; 37(2):97-104. PubMed ID: 2370032
    [Abstract] [Full Text] [Related]

  • 33. The pathogenicity of Entamoeba histolytica is related to the capacity of evading innate immunity.
    Campos-Rodríguezp R, Jarillo-Luna A.
    Parasite Immunol; 2005 May; 27(1-2):1-8. PubMed ID: 15813717
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Protective immunity to entamoeba histolytica infection in subjects with antiamoebic antibodies residing in a hyperendemic zone.
    Choudhuri G, Prakash V, Kumar A, Shahi SK, Sharma M.
    Scand J Infect Dis; 1991 May; 23(6):771-6. PubMed ID: 1815341
    [Abstract] [Full Text] [Related]

  • 37. Immune markers characteristic for asymptomatically infected and diseased Entamoeba histolytica individuals and their relation to sex.
    Bernin H, Marggraff C, Jacobs T, Brattig N, Le VA, Blessmann J, Lotter H.
    BMC Infect Dis; 2014 Nov 25; 14():621. PubMed ID: 25420932
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Differences between the large and small intestine in the immunodominant amoebic proteins recognized by IgG and IgA antibodies in BALB/c mice.
    Moreno-Fierros L, López-Revilla R, Reséndiz-Albor AA.
    Scand J Immunol; 2002 May 25; 55(5):458-69. PubMed ID: 11975757
    [Abstract] [Full Text] [Related]

  • 40. Recent discoveries in the pathogenesis and immune response toward Entamoeba histolytica.
    Lejeune M, Rybicka JM, Chadee K.
    Future Microbiol; 2009 Feb 25; 4(1):105-18. PubMed ID: 19207103
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.